Admapag-25 Tablet 28's

Admapag-25 Tablet 28's is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Admapag-25 Tablet 28's is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.

Admapag-25 Tablet 28's contains 'Eltrombopag', which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Admapag-25 Tablet 28's works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Admapag-25 Tablet 28's helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.

Take Admapag-25 Tablet 28's as prescribed by your doctor. In some cases, Admapag-25 Tablet 28's can cause common side effects like nausea, diarrhoea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. These side effects are not familiar to everyone who takes Admapag-25 Tablet 28's and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you have any allergic reactions to Admapag-25 Tablet 28's or any other medicines before starting Admapag-25 Tablet 28's. It is essential to inform your doctor if you have any heart, kidney or liver problems, blood disorders, blood clotting problems and cataracts before starting Admapag-25 Tablet 28's. Consult the doctor if you are pregnant or planning to conceive. Admapag-25 Tablet 28's is not indicated for use in breastfeeding since it passes into the breast milk. Admapag-25 Tablet 28's may make you dizzy; hence, drive or operate machinery only when you are mentally alert. 

Admapag-25 Tablet 28's contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults. Admapag-25 Tablet 28's works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus Admapag-25 Tablet 28's prevents bleeding episodes by increasing the number of platelets in the blood.

If you are known to be allergic to Admapag-25 Tablet 28's or other medicines, please inform your doctor in advance. Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Admapag-25 Tablet 28's. Take Admapag-25 Tablet 28's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Admapag-25 Tablet 28's. Admapag-25 Tablet 28's is not recommended during pregnancy since it may have harmful effects on the foetus. Consult your doctor before using Admapag-25 Tablet 28's if you are a breastfeeding mother. Do not drive or operate machinery since Admapag-25 Tablet 28's may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive. Avoid or limit alcohol consumption with Admapag-25 Tablet 28's as it may affect the efficacy of Admapag-25 Tablet 28's. Admapag-25 Tablet 28's is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.